SAT0141 Predictive factors for radiographic progression in low- and standard-dose etanercept therapy for rheumatoid arthritis from the prevention of cartilage destruction by etanercept (precept) study

Abstract

BackgroundThe combination of etanercept (ETN) and methotrexate can inhibit the progression of joint destruction. However, biological therapy imposes to an economic burden on patients. To reduce the treatment cost of...